SCHEMBL6013496

SCHEMBL6013496

COc1ccc2[nH]c(C)c(CC(=O)O)c2c1C(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 1/20 0.49
MAPT P10636 7/20 0.49
KDM4E B2RXH2 6/20 0.49
GAA P10253 5/20 0.49
ALDH1A1 P00352 2/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
POLB P06746 1/20 0.44
CYP1A2 P05177 3/20 0.43
CYP2C19 P33261 2/20 0.43
CYP3A4 P08684 2/20 0.43
LMNA P02545 2/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALOX15 P16050 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9017484 0.91 AKR1C2 (0.56) AKR1C2MAPTKDM4EGAAALDH1A1
SCHEMBL998208 0.90 AKR1C2 (0.46) AKR1C2MAPTKDM4EGAAALDH1A1
SCHEMBL7755896 0.88 AKR1C2 (0.43) AKR1C2MAPTKDM4EGAAALDH1A1
SCHEMBL2007216 0.87 AKR1C2 (0.44) AKR1C2MAPTKDM4EGAAALDH1A1
SCHEMBL5496301 0.86 AKR1C2 (0.46) AKR1C2MAPTKDM4EGAAALDH1A1
SCHEMBL9017474 0.85 ALDH1A1 (0.43) AKR1C2MAPTKDM4EGAAALDH1A1
SCHEMBL5499426 0.84 AKR1C2 (0.48) AKR1C2MAPTKDM4EGAAALDH1A1
SCHEMBL9017473 0.83 AKR1C2 (0.47) AKR1C2MAPTKDM4EGAAALDH1A1
SCHEMBL11466556 0.81 MAPT (0.45) AKR1C2MAPTKDM4EALDH1A1MEN1
SCHEMBL7693001 0.81 AKR1C2 (0.49) AKR1C2MAPTKDM4EGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1617828-A2 NANO-SIZED VEHICLES TRANSPORTING A THERAPEUTIC AGENT AND AT LEAST ONE DRUG RESISTANCE MODULATOR FOR THE TREATMENT OF MULTI DRUG RESISTANCE Celator Pharmaceuticals, Inc. (US) 2006-01-25 EP disclosed
WO-2004087094-A2 NANO-SIZED VEHICLES TRANSPORTING A THERAPEUTIC AGENT AND AT LEAST ONE DRUG RESISTANCE MODULATOR FOR THE TREATMENT OF MULTI DRUG RESISTANCE CELATOR PHARMACEUTICALS, INC. (US) 2004-10-14 WO disclosed
EP-0746544-A1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMACEUTICALS INC. (US) 1996-12-11 EP disclosed
WO-1995022524-A1 NOVEL INDOLE DERIVATIVES USEFUL TO TREAT ESTROGEN-RELATED NEOPLASMS AND DISORDERS MERRELL PHARMACEUTICALS INC. (US) 1995-08-24 WO disclosed